Bioresorbable Vascular Scaffolds-Reference-Cited by-同舟云学术

Bioresorbable Vascular Scaffolds

Published:2016-03 Issue:6 Volume:9 Page:575-577
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference11 articles.

1. Back to School - Call Me When You Have No Class. Available at: http://youtu.be/bJaz_S4deTM. Accessed January 29, 2016.

2. Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions;Abizaid;J Am Coll Cardiol Intv,2016

3. Five-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial;Gada;J Am Coll Cardiol Intv,2013

4. Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation;Yamaji;Circ Cardiovasc Interv,2010

5. Onuma Y, Nakatani S, van Geuns RJ, Lara JG, Serruys PW. Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies. Available at: http://www.tctmd.com/show.aspx?id=126636. Accessed January 10, 2016.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging and 2‐year clinical outcomes of thin strut sirolimus‐eluting bioresorbable vascular scaffold: The MeRes ‐1 extend trial;Catheterization and Cardiovascular Interventions;2020-12-02

2. Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis;Frontiers in Bioengineering and Biotechnology;2020-06-24

3. How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials;EuroIntervention;2019-05

4. Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study;EuroIntervention;2018-12

5. Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes;The American Journal of Cardiology;2018-07